- Aisi ki taisi of tariffs imposed by President Trump
- Earlier this year, a well-known pharmaceutical company launched the obesity drug Monjaro in India
American companies are looking for a way to circumvent the political and H-1B visa restrictions imposed by US President Trump so that their margins can be maintained. As part of this, an American pharma company is to invest one billion dollars, i.e. about Rs 8,880 crore, in India by aisi ki taisi of Trump’s tariffs. This is proof of how much faith American companies have in Indian talent.
America’s Eli Lilly & Company is to invest one billion dollars, i.e. Rs 8,880 crore, in India. Surprisingly, the American company’s readiness to invest in India in a situation where political relations between the two countries are strained over tariffs shows how confident the company is about investing in India.
